|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.98 USD | -2.29% |
|
0.00% | -9.67% |
| May. 10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
| May. 09 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M | MT |
TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.67% | 147M | |
| -4.77% | 182B | |
| +4.10% | 114B | |
| -3.85% | 67.76B | |
| +5.19% | 51.91B | |
| +5.54% | 43.23B | |
| +5.96% | 41.07B | |
| +23.81% | 32.07B | |
| +16.05% | 25B | |
| -5.06% | 24.35B |
TELA BIO, INC. 
